Provided by Tiger Trade Technology Pte. Ltd.

Pacira Pharmaceuticals

24.83
+0.16000.65%
Volume:186.54K
Turnover:4.62M
Market Cap:989.77M
PE:70.59
High:25.04
Open:24.60
Low:24.49
Close:24.67
52wk High:27.66
52wk Low:18.80
Shares:39.86M
Float Shares:36.37M
Volume Ratio:0.46
T/O Rate:0.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3518
EPS(LYR):0.1578
ROE:2.05%
ROA:1.48%
PB:1.47
PE(LYR):157.32

Loading ...

Mar 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 29, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 29, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 29, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 04, 2024

Major Issues Report

Form 8-K - Current report
Dec 21, 2023

Major Issues Report

Form 8-K - Current report
Nov 13, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 02, 2023

Major Issues Report

Form 8-K - Current report
Oct 10, 2023

Major Issues Report

Form 8-K - Current report
Oct 07, 2023

Correspondence

Form CORRESP - Correspondence
Sep 27, 2023

Major Issues Report

Form 8-K - Current report
Sep 12, 2023

Major Issues Report

Form 8-K - Current report
Aug 03, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 02, 2023

Major Issues Report

Form 8-K - Current report
Aug 02, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 05, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 21, 2023

Major Issues Report

Form 8-K - Current report